Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia

Published:2004 Issue:12 Volume:100 Page:2583-2591
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Tsimberidou Apostolia M.,Keating Michael J.,Giles Francis J.,Wierda William G.,Ferrajoli Alessandra,Lerner Susan,Beran Miloslav,Andreeff Michael,Kantarjian Hagop M.,O'Brien Susan

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference51 articles.

1. Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy

2. Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia

3. The Role of Nucleoside Analogues in the Treatment of Chronic Lymphocytic Leukemia-Lessons Learned from Prospective Randomized Trials

4. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marine Nucleosides: Structure, Bioactivity, Synthesis and Biosynthesis;Marine Drugs;2014-12-02

2. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells;European Journal of Pharmacology;2013-12

3. Treatment of Chronic Lymphocytic Leukemia and Related Disorders;Neoplastic Diseases of the Blood;2012-07-27

4. Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia;Cancer Control;2012-01

5. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2010-11